Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase
- 30 June 1993
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 101 (1) , 117-125
- https://doi.org/10.1016/0021-9150(93)90107-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Regulation of intracellular actin polymerization by prenylated cellular proteinsThe Journal of cell biology, 1992
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- Prevention of restenosis by lovastatin after successful coronary angioplastyAmerican Heart Journal, 1991
- Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytesPharmacological Research, 1991
- Regulation of the mevalonate pathwayNature, 1990
- Effects of a Competitive Inhibitor (Mevinolin) of 3‐Hydroxy‐3‐methylglutaryl Coenzyme A Reductase on Human and Bovine Endothelial Cells, Fibroblasts and Smooth Muscle Cells in VitroBasic & Clinical Pharmacology & Toxicology, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A ReductaseEuropean Journal of Biochemistry, 1978